Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Ocugen
Ocugen to Host Webcast on Tuesday, March 24 at 8 a.m. EDT to Discuss Phase 2 Clinical Trial Data for OCU410—Modifier Gene Therapy for Geographic Atrophy
May 22, 2026
Ocugen Provides Business Update with Fourth Quarter and Full Year 2025 Financial Results
May 16, 2026
Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common Stock
January 23, 2026
Ocugen, Inc. Announces Pricing of $22.5 Million Offering of Common Stock
January 21, 2026
←
Previous Page
1
2